CDK5-IN-3 |
| Catalog No.GC66009 |
CDK5-IN-3 (compuesto 11) es un inhibidor potente y selectivo de CDK5, con IC50 de 0,6 nM y 18 nM para CDK5/p25 y CDK2/CycA, respectivamente. CDK5-IN-3 se puede utilizar para la investigaciÓn de la enfermedad renal poliquÍstica autosÓmica dominante (ADPKD).
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2639542-32-6
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
CDK5-IN-3 (compound 11) is a potent and selective CDK5 inhibitor, with IC50s of 0.6 nM and 18 nM for CDK5/p25 and CDK2/CycA, respectively. CDK5-IN-3 can be used for the research of autosomal dominant polycystic kidney disease (ADPKD)[1].
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *